ABC (Atrial fibrillation Better Care) pathway and healthcare costs in atrial fibrillation. The ATHERO-AF study

Patients with atrial fibrillation are often elderly and have multiple comorbidities, leading to a high risk of cardiovascular events1,2,3 despite the use of oral anticoagulants, whether with the vitamin K antagonists (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs).

Leave a Reply

Your email address will not be published. Required fields are marked *